Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02842086
Brief Title: Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection (DISCOVER)

First Submitted : July 20, 2016
First Submitted that Met QC Criteria : July 20, 2016
First Posted : July 22, 2016 (Estimate)

Results First Submitted : January 29, 2020
Results First Submitted that Met QC Criteria : March 3, 2020
Results First Posted : March 17, 2020

Last Update Submitted that Met QC Criteria : December 21, 2020
Last Update Posted : January 12, 2021